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Further Studies on Insulin Augmentation Capacities 
of Various Serum Proteins 
The ability of human serum protein to termined. The property was found to be 
augment the action of crystalline insulin present in all fractions, but concentrated 
on the epididymal fat pad has been to a slightly greater extent in the faster- 
further evaluated. Serum proteins were moving gamma globulins and beta glob- 
fractionated by elution from DEAE cel- ulins. The augmentation effect has again 
lulose and the capacity of individual been found to be deficient in diabetes 
fractions to augment insulin action de- mellitus. 
W 
HEN CRYSTALLINE INSULIN is added to undiluted human serum, 
its activity is completely recovered in the epididymal fat insulin assa> 
system. When insulin is added to diluted human serum in the same system, 
Gowel~rr, its activity has been found to be augmented.’ This augmentatiolr 
effect has further been found to be glucose-responsive, to be present in the 
5cirum globulins, and to be deficient in the serum of patients with diabetes 
mellitus.‘.’ The present study was undertaken to make a more definiti\,cb 
separation of the serum protein fractions than had been made previously.” itr 
an &fort to determine which fraction contains the greatest cplantity of ;HI;~- 
mentation activity. 
Norrnul Subjects urd Diubetic Pllticnts 
Six healthy nonobese y-oung adnlts. from 31 to 28 years of a,~, without family histories 
of diabetes and with normal carbohydrate tolerance, served as control subjects. Six ma- 
tllrity-onset type diabetic patients from 23 to 45 years of age, with family histories c)f 
diabrtr~ and with fasting blood sugars of 110 mg. p~sr cent or less, comprised this CS- 
prrimcntal group. Two cxucceded ideal weight by 10 per cent and one by 15 per cent. TIM* 
rcsmaining 3 were of normal weight. None had been treated. Blood was drawn in tllc. 
t’zting state and the serum stored at -_“O C. 
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Fig. S.-Distribution of ILA in serum protein fractions of normal and diabetic 
subjects in the fasting state. 
Serzrm Fractionation 
Within 3 weeks of collection, serum was separated into albumin and globulin compo- 
nents by dialysis against ammonium sulfate, and the globulin component further separated 
by clution from diethylaminoethyl ( DEAE ) cellulose. Seven firactions were derived from 
each globulin component.” Each was dialyzed against an infinite volume of distilled 
water. and lyophilized. For assay, each fraction was dissolved in Krebs bicarbonate 
buff‘er at a concentration of 1 mg./ml. Crystalline insulin on a gelatin carrier was added 
to each as well as to buffer alone for simultaneous assay of its activity.1 
RESULTS 
The electrophoretic composition and insulin-like activity (ILA) of the 
separated globulin fractions are shown in figures 1 and 2. These results have 
been previously reported.” The protein composition of each fraction was 
determined by paper eleetrophoresis. Their ILA was measured using a modi- 
fication of the epididymal fat pad method.4 Separation of serum into albumin 
and globulin by dialysis against ammonium sulfate was incomplete and heavy 
albumin concentrations appeared in the later cellulose fractions, as can be 
seen in figure 1. 
The effect of adding approximately 200 VU of crystalline insulin to each 
mg. of protein from the individual fractions is shown in figures 3 and 4. The 
solid-colored base of each column represents the ILA of a mg. of protein 
from that fraction and the hatched areas represent the separately-meas- 
ured activity of the added insulin. The open areas above represent the ex- 
tent of augmentation as determined by measurement of the ILA of a solu- 
tion of both the particular fraction and the added insulin. The augmentation 
effect is seen in all fractions from the normal subjects as well as in those of 
the diabetic patients. A slight peak of activity is apparent in that fraction 
containing the faster-moving gamma globulins, and perhaps some beta globu- 
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Fig. 3.-Augmentation of iusulill uction bv S~LIIII protein fractions of fasting 
normal subjects. 
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Fig. 4.-Augmentation of insulin action by serlun protein fractions of fasting 
untreated diabetic patients. 
lins as well. Diabetic patients showed a consistently impaired augmentation 
capacity compared to normal subjects ( p < .Ol ) . 
DISCUSSION 
These studies have extended previous observations on the behavior of a 
factor in human serum capable of augmenting the action of insulin on adipose 
tissue and muscle in vitro. Augmentation activity has been found in all the 
serum protein fractions with a slightly increased concentration in the gamma- 
beta globulins. Because previous studies had indicated this property to be 
glucose-responsive and to be deficient in patients with diabetes mellitus, it 
was suggested that it might be related to a difference in the circulating insulin 
moiety.2 If such were the case, and if ILA were a single moiety, augmentation 
would then be expected to parallel the concentration of ILA in any given 
protein fraction, As these studiess show, however, augmentation is highest in 
fraction no. 2, while ILA is highest in fractions nos. 3 and 4. Thus in these 
experiments, ILA and augmentation capacity seem unrelated. Three major 
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possibilities exist: (1) that there are se\reral entities in serum protein wit11 
insulin-like activity but different augmentation capacities; (2) that there is 
only one entity in serum protein with ILA and augmentation capacitv but 
separatory technics have partly denatured it and led to the different distribu- 
tion of ILA and augmentation; and (3) that augmentation is not a proper?\ 
of the circulating insulin moiety, but a previously unrecognized factor or 
factors. 
A more serious objection to the hypothesis that augmentation is a propert! 
of circulating endogenous insulin is the diffuseness of its distribution in the 
sc‘rrun proteins. A discrete entity generally associates itself with one of the 
serum proteins to a greater degree than that observed in the present stud\,. 
This consideration leads to the possibility that the serum proteins ha\rc ~&II 
altered by the manipulations and that augmentation results from an unrrcog- 
nized artifact. Such an artifact, however, would have to he induced In 
maniprilations of serum as gentle as dilution; diabetic serum would have tcr 
1;~ IWS susceptible to the induction of artifact than normal; and normal scrrrm 
woiild have to be more susceptible after glucose loading. These considerations 
argiic ’ against this possibility. 
I\‘ere the insulin moiety a small protein molecule, it could exhibit the wide 
distribution among serum proteins that has been found. Under such circum- 
stances, its slight affinity for the gamma-beta globulins might reflect a 
capacity of the latter to bind nonspecifically, rather than a capacity of the 
small moiety to be specifically bound. 
A final consideration arising from the present sturdy, dcrivrs from 0111 
dt,llloilstratioil of the augmentation phenomenon in fractions c~omposed 1” 63 
dominantly of alhmnin. an observation in line with the findings of Alp ct al.,- 
;rntl in contrast to earlier findings of our OWII.~ The easiest explanation for the 
discrepancy is a difference in methods, the “albumin” of the different stlldies 
being isolated by different technics and containing different proteins. ~11 
alternative explanation can hc developed from a property peculiar to the 
arrgmentation effect in whole serum. Intact serllm does not augment tllc, 
ac+i\+tv of added insulin, yet it contains this capacity. In a similar way, airg- 
mentation may be masked in some of the more heterogeneous serum protc,iIl 
fractions. Separation of serum globulins in the present work has revealed a 
greater total capacity to augment than was suspec:ted from previolls stuclies 
of Illlseparated globulin.” That these findings reflect the existence of a l)loc~k- 
ing propert! eventually eliminated hy technical maniplllationq, remains 2 
possihilitv. 
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